Understanding the DUPLEX Trial and Sparsentan in FSGS, with

Michelle Rheault, MD, provides additional perspective on the results of the DUPLEX trial, which examined sparsentan in patients with FSGS.

Related Keywords

United States , American , Michelle Rheault , Guruswamy Sangameswaran , University Of Minnesota Michelle Rheault , University Of Minnesota , American Society Of Nephrology Kidney Week , American Society , Nephrology Kidney Week , Kidney Week , Treasure Island , Statpearls Publishing , Focal Segmental , New England Journal ,